Gossamer Bio, Inc.
GOSS· Nasdaq
GOSSGossamer Bio, Inc.
Filed Nov 8, 2021 · 10-Q · 39 days after period end · 0001728117-21-000104
| Metric | Q3 2021 | Q3 2020 | Q3 2019 | Q3 2018 |
|---|---|---|---|---|
| Net Income | -$60.25M | -$57.81M | -$48.50M | -$49.41M |
| EPS Diluted | -$0.80 | -$0.80 | -$0.80 | -$8.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Gossamer Bio, Inc. · CIK 1728117 · Engraved from SEC EDGAR
ended Sep 30, 2021 · filed Nov 8, 2021 · 39 d after period end
